TD Cowen Cuts Globe Life (GL) Price Target to $215
Key Points
- TD Cowen maintained its Buy rating on Globe Life Inc. GL on October 23, 2026, while adjusting its price target down to $215 from $225.
- TD Cowen's $215 price target implies 27.66% upside from Globe Life Inc.'s ($GL) current $168.41 share price.
- Globe Life generated trailing twelve-month revenue of $6.27 billion alongside earnings of $14.94 per share.
- Eleven analysts track the stock, resulting in a consensus buy recommendation and an average price target of $192.09.
Get Globe Life text alerts
We text you when insiders, Congress, analysts or big funds move on $GL.
By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated Globe Life Inc. alert may contain errors. Disclosures
On October 23, 2026, TD Cowen maintained its Buy rating on Globe Life Inc. GL while lowering its price target from $225.00 to $215.00. Research notes from the firm outline its forward-looking view on the insurance provider following recent sector updates. Globe Life closed at $168.41 on October 22, 2026.
GL
Globe Life Inc.
TD Cowen vs. the S&P 500
Hypothetical returns from TD Cowen's disclosed trades, not real profit or advice. How we model this.
TD Cowen's Call on Globe Life Inc.
TD Cowen kept its positive stance on the insurance company intact on October 23, 2026, while trimming the target by $10.00 to $215.00. The adjustment follows earlier target updates across Wall Street, including moves by Wells Fargo and JP Morgan earlier in October.
Other Institutional Activity in Globe Life Inc.
AQR Capital Management, LLC grew its holdings by 318,052 shares, ending with 1,515,987 shares worth about $255,307,376. Nuveen, LLC reduced its stake by 2,248 shares, finishing with 1,496,640 shares valued around $252,049,147.
Globe Life Inc. Stock Down 0.7%
The stock recently traded around $168.41 as of October 23, 2026, remaining close to its prior closing level. Shares sit below the 50-day moving average of $170.58 while staying above the 200-day moving average of $159.22.
$GL price target
Globe Life Inc. daily closes and this analyst's $215 target. Not advice.
Recent Earnings
Globe Life generated trailing twelve-month revenue of $6,274,907,136 and trailing twelve-month earnings of $14.94 per share. The company posted a net profit margin of 18.9% and year-over-year revenue growth of 5.5%. Investors look toward the next earnings report scheduled for February 3, 2027.
Dividend
Globe Life pays an annual dividend rate of $1.32 per share, yielding 0.78% with a payout ratio of 8.0%.
Insider Buying and Selling at Globe Life Inc.
Insiders completed several transactions prior to the update, including officer Michael Clay Majors selling 37,000 shares worth $6,609,525 on July 29, 2026. Chief Financial Officer Thomas Peter Kalmbach sold 21,000 shares for $3,781,162 on July 30, 2026. Chief Executive Officer James Matthew Darden sold 50,000 shares valued at $9,121,638 on July 31, 2026. Chief Investment Officer Robert Edward Hensley sold 10,000 shares worth $1,700,701 on September 22, 2026.
Analysts Set New Price Targets
Wells Fargo maintained an Overweight rating with a target of $191.00 on October 12, 2026. JP Morgan maintained an Overweight rating with a target of $195.00 on October 15, 2026. Evercore ISI Group maintained an In-Line rating with a target of $174.00 on October 23, 2026. Piper Sandler downgraded the stock to Neutral with a target of $165.00 on October 23, 2026. Overall, the stock carries a consensus buy rating from 11 analysts with a mean price target of $192.09.
About Globe Life Inc.
Globe Life Inc. provides life and supplemental health insurance products to families across the United States. The company operates through life insurance, supplemental health insurance, and investment segments.
Bottom Line
TD Cowen's decision to maintain its Buy rating highlights confidence in the insurer's business model despite a lower price target. Market participants will watch upcoming earnings on February 3, 2027, for further insight into financial performance.
Related Filing Alerts
Source: TD Cowen's rating change on $GL (Oct 23, 2026). Written by software, not financial advice. How we make alerts